These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9570459)

  • 21. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ataxia-ameliorating effects of YM-14673, a potent analog of thyrotropin releasing hormone, in ataxic mutant mice.
    Matsui K; Wada K; Kwak S
    Eur J Pharmacol; 1994 Mar; 254(3):295-7. PubMed ID: 8013566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues.
    Ogawa N; Mizuno S; Mori A; Nukina I; Ota Z; Yamamoto M
    Peptides; 1984; 5(4):743-6. PubMed ID: 6436797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-talk between excitatory and inhibitory amino acids in the regulation of growth hormone secretion in neonatal rats.
    Pinilla L; Gonzalez LC; Tena-Sempere M; Aguilar E
    Neuroendocrinology; 2001 Jan; 73(1):62-7. PubMed ID: 11174018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute administration of alcohol modulates pyroglutamyl amino peptidase II activity and mRNA levels in rat limbic regions.
    de Gortari P; Romero F; Cisneros M; Joseph-Bravo P
    Neurochem Int; 2005 Mar; 46(4):347-56. PubMed ID: 15707699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1.
    Kaur N; Monga V; Lu X; Gershengorn MC; Jain R
    Bioorg Med Chem; 2007 Jan; 15(1):433-43. PubMed ID: 17035026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyrotropin-releasing hormone and its receptor in the cerebellum of inferior olive destroyed rat brain.
    Adachi K; Rhue BN; Li M; Izumi M; Osano H; Mitsuma T
    Neurol Res; 2000 Jun; 22(4):401-3. PubMed ID: 10874690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low affinity analogs of thyrotropin-releasing hormone are super-agonists.
    Engel S; Neumann S; Kaur N; Monga V; Jain R; Northup J; Gershengorn MC
    J Biol Chem; 2006 May; 281(19):13103-13109. PubMed ID: 16551618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyrotropin-releasing hormone facilitates spinal nociceptive responses by potentiating NMDA receptor-mediated transmission.
    Chizh BA; Headley PM
    Eur J Pharmacol; 1996 Apr; 300(3):183-9. PubMed ID: 8739206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-ataxic effects of TRH and its analogue, TA-0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegmental area.
    Kinoshita K; Watanabe Y; Asai H; Yamamura M; Matsuoka Y
    Br J Pharmacol; 1995 Dec; 116(8):3274-8. PubMed ID: 8719807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a new TRH analogue, YM-14673, on spontaneous motor activity in rats.
    Shimizu M; Yamamoto M; Kobayashi M
    Arch Int Pharmacodyn Ther; 1989; 301():100-11. PubMed ID: 2516440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRH-analog, TA-0910 (3-methyl-(s)-5,6-dihydroorotyl-L-histidyl-L-prolinamide) rescues motor neurons from axotomy-induced cell death.
    Iwasaki Y; Shiojima T; Tagaya N; Kobayashi T; Kinoshita M
    Neurol Res; 1997 Dec; 19(6):613-6. PubMed ID: 9427962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NS-3 (CG3703), an analog of thyrotropin-releasing hormone, ameliorates cognitive impairment in rats.
    Ogasawara T; Ukai Y; Tamura M; Kimura K
    Pharmacol Biochem Behav; 1995 Apr; 50(4):499-503. PubMed ID: 7617693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)].
    Yamamura M; Suzuki M; Matsumoto K
    Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():33P-38P. PubMed ID: 9503402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
    Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selectivity-based QSAR approach for screening and evaluation of TRH analogs for TRH-R1 and TRH-R2 receptors subtypes.
    Kadam RU; Chavan AG; Monga V; Kaur N; Jain R; Roy N
    J Mol Graph Model; 2008 Oct; 27(3):309-20. PubMed ID: 18595758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potency of the N3im-methyl analog of TRH in the induction of shaking movements in the rat.
    Wei E; Loh H; Way EL
    Eur J Pharmacol; 1976 Mar; 36(1):227-9. PubMed ID: 816658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic anti-ataxic actions of the novel thyrotropin-releasing hormone (TRH) analog, TA-0910, during and after repeated administration in Rolling mouse Nagoya: behavioral and pharmacokinetic studies.
    Kinoshita K; Fukushima T; Kodama Y; Sugihara J; Yamamura M; Matsuoka Y
    Biol Pharm Bull; 1997 Jan; 20(1):36-9. PubMed ID: 9013803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models.
    Kelly JA; Boyle NT; Cole N; Slator GR; Colivicchi MA; Stefanini C; Gobbo OL; Scalabrino GA; Ryan SM; Elamin M; Walsh C; Vajda A; Goggin MM; Campbell M; Mash DC; O'Mara SM; Brayden DJ; Callanan JJ; Tipton KF; Della Corte L; Hunter J; O'Boyle KM; Williams CH; Hardiman O
    Neuropharmacology; 2015 Feb; 89():193-203. PubMed ID: 25281210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.